US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 3, 2023 (3 years ago)

Atropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Particulate Matter: Particulate matter identified as fiber.

What was recalled

Atropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose Vials, Rx only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited Ahmedabad-382 210, India, NDC 16729-512-43.

Recalling firm
Accord Healthcare, Inc.
NDC code
16729-512-43
Origin
NC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0917-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Atropine recalls

See all